Table 6.
Long-Term Visual Outcomes
Long-Term Visual Outcomes | MOG-IgG + ON | AQP4-IgG + ON | p-value |
---|---|---|---|
Final VA | |||
● Final VA, median (range), logMAR | 0.0 (0–0.48) | 0.4 (0–2.9) | < 0.001* |
● Final VA worse than or equal to 1.0 logMAR, n of eyes/n of eyes with available data (%) | 0/28 (0.0) | 19/55 (34.6) | < 0.001* |
ON relapse, n of patients (%) | 7 (43.8) | 25 (58.1) | 0.32 |
ON ARR, median (range) | 0.56 (0.11–2.50) | 0.35 (0.13–1.40) | 0.20 |
Time from ON onset to first ON relapse, median (range), months | 7 (5–38) | 17 (3–90) | 0.25 |
Note: *Statistically significant (p < 0.05).
Abbreviations: ON, optic neuritis; MOG-IgG +, myelin oligodendrocyte glycoprotein autoantibody-positive; AQP4-IgG +, aquaporin-4 autoantibody-positive; VA, visual acuity; logMAR, logarithm of the minimum angle of resolution; n, number; ARR, annualized relapse rate.